LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

NCT ID: NCT06632444

The LIVERAGE™ clinical trial is studying a medication called survodutide to see if it can help adults with a liver disease known as Metabolic Dysfunction Associated Steatohepatitis (MASH) who also ...

Recruiting

Phase: PHASE3 Conditions: Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis (MASH)

A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

NCT ID: NCT06769048

This clinical trial is studying a medication called BI 1584862 to see if it can help improve vision in adults aged 55 and older who have a specific type of age-related macular degeneration (AMD) kn...

Recruiting

Phase: PHASE2 Conditions: Geographic Atrophy

A Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Selected Surgeries

NCT ID: NCT06887959

This clinical trial is looking at a new medication called Suzetrigine (SUZ) to see how well it works and how safe it is for managing acute pain after certain types of surgeries. Specifically, the s...

Recruiting

Phase: PHASE4 Conditions: Acute Pain

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

NCT ID: NCT05006716

This clinical trial is studying a new treatment called BGB-16673 for patients with specific types of B-cell cancers, such as Marginal Zone Lymphoma, Follicular Lymphoma, and Chronic Lymphocytic Leu...

Recruiting

Phase: PHASE1 Conditions: Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma +7 more

Study of Oral MRT-2359 in Selected Cancer Patients

NCT ID: NCT05546268

This clinical trial is studying a new treatment called MRT-2359 for patients with specific types of cancer, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and certain ...

Recruiting

Phase: PHASE1 Conditions: Prostate Cancer, NSCLC +6 more

Platform Clinical Study for Conquering Scleroderma

NCT ID: NCT06195072

The "Platform Clinical Study for Conquering Scleroderma" is a clinical trial designed to investigate new treatments for patients suffering from Interstitial Lung Disease (ILD) caused by scleroderma...

Recruiting

Phase: PHASE2 Conditions: Scleroderma, Interstitial Lung Disease Due to Systemic Disease

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

NCT ID: NCT06425926

This clinical trial is studying a new treatment called GIM-531 for patients with advanced solid tumors, specifically Stage IV melanoma. GIM-531 is a type of medication that is taken by mouth and is...

Recruiting

Phase: PHASE1 Conditions: Solid Tumor, Melanoma Stage IV

Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch

NCT ID: NCT06751056

This clinical trial is investigating whether a treatment called cervical traction can help reduce the need for certain medications, specifically gabapentin or pregabalin, in people experiencing neu...

Recruiting

Phase: NA Conditions: Pruritus

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

NCT ID: NCT06782490

This clinical trial is studying a new medication called BMS-986368 to see how well it works, how safe it is, and how well people can tolerate it for treating spasticity in individuals with Multiple...

Recruiting

Phase: PHASE2 Conditions: Multiple Sclerosis Spasticity

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

NCT ID: NCT06937229

The ADAGIO-3 study is a clinical trial focused on testing a new treatment for agitation in people with Alzheimer’s Disease. This trial will specifically look at the long-term effects and safety of ...

Not yet recruiting

Phase: PHASE3 Conditions: Alzheimer Disease, Agitation

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

NCT ID: NCT05843643

This clinical trial is studying the safety and effectiveness of a medication called upadacitinib for adults with moderate to severe systemic lupus erythematosus (SLE), a disease that causes inflamm...

Recruiting

Phase: PHASE3 Conditions: Systemic Lupus Erythematosus

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT ID: NCT06290141

This clinical trial is studying a new medication called riliprubart to see how well it works compared to the usual treatment with intravenous immunoglobulin (IVIg) for adults with Chronic Inflammat...

Recruiting

Phase: PHASE3 Conditions: Chronic Inflammatory Demyelinating Polyneuropathy

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

NCT ID: NCT06467357

This clinical trial is looking at new treatment options for patients with advanced biliary tract cancer (BTC) that expresses a protein called HER2. Specifically, the study compares a combination of...

Recruiting

Phase: PHASE3 Conditions: Biliary Tract Cancer

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT ID: NCT03866382

This clinical trial is investigating how well three medications—cabozantinib, nivolumab, and ipilimumab—work together to treat patients with rare genitourinary tumors that have spread to other part...

Recruiting

Phase: PHASE2 Conditions: Stage IVB Prostate Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 +43 more

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

NCT ID: NCT04402788

The RAPTOR Trial is a clinical study looking at whether adding radiation therapy to the usual treatment with atezolizumab can help patients with extensive stage small cell lung cancer. This type of...

Recruiting

Phase: PHASE2 Conditions: Extensive Stage Lung Small Cell Carcinoma

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

NCT ID: NCT03937635

This clinical trial is studying how effective a combination of three medications—lenalidomide, dexamethasone, and daratumumab—are in treating patients with high-risk smoldering myeloma. Smoldering ...

Recruiting

Phase: PHASE3 Conditions: Smoldering Plasma Cell Myeloma

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

NCT ID: NCT05047172

This clinical trial is looking to compare different blood-thinning medications to see which is most effective in preventing strokes and other serious issues related to narrowed blood vessels in the...

Recruiting

Phase: PHASE3 Conditions: Stroke, Intracranial Arteriosclerosis

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

NCT ID: NCT05579366

This clinical trial is investigating a new drug called PRO1184 for patients with various types of advanced solid tumors, including different forms of ovarian, lung, and breast cancer. The main goal...

Recruiting

Phase: PHASE1 Conditions: Non-small Cell Lung Cancer, Endometrial Cancer +13 more

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

NCT ID: NCT05754957

This clinical trial is studying a medication called milvexian to see if it can help reduce the risk of serious heart problems in patients who have recently experienced an acute coronary syndrome (A...

Recruiting

Phase: PHASE3 Conditions: Acute Coronary Syndrome

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

NCT ID: NCT05889182

This clinical trial is studying a medication called upadacitinib to see how effective and safe it is for treating moderate to severe hidradenitis suppurativa (HS) in adults and adolescents who have...

Recruiting

Phase: PHASE3 Conditions: Hidradenitis Suppurativa

Main Menu

Clinical Trials in Scottsdale, Arizona

436 Active Trials Found in Scottsdale

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

A Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Selected Surgeries

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

Study of Oral MRT-2359 in Selected Cancer Patients

Platform Clinical Study for Conquering Scleroderma

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy